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doi:10.1016/j.ejvs.2008.04.012Abstract Objective: To evaluate the efficacy of peripheral angioplasty (PTA) in the treat-
ment of diabetic patients with previous peripheral bypass graft and recurrent critical limb is-
chemia (CLI).
Methods: Between January and December 2006, 293 diabetic patients presenting with critical
limb ischemia (CLI) according to the TASC 2000 criteria were admitted to our footcare centre.
Among these patients, 32 of them had previously undergone bypass grafting: femoropopliteal
in 26 patients, femoroposterior tibial in 3 patients, femoroperoneal in the remaining 3. All
these patients underwent angiography and, whenever possible, a concomitant PTA procedure.
Results: Six patients presented with stenosis at the distal anastomosis, 2 with stenosis at the
proximal anastomosis and in 5 patients both the distal and proximal anastomosis were
stenosed. In 12 patients the graft was completely occluded. In 7 patients the graft appeared
patent but all the infrapopliteal arteries were occluded. The average time interval between
bypass and subsequent hospital admission because of CLI was 6.3 4.2 months for patients
with patent grafts and 20.5 12.0 months for those with failing grafts (pZ 0.004).
A successful PTA was performed in 25 patients (78.1%). In all patients with patent grafts, PTA
recanalized one infrapopliteal artery. Recanalization of the graft was obtained in all 13
patients with non-occluded graft. Recanalization of superficial femoral artery occlusion by
means of PTA was obtained in 5 out of the 12 patients in whom the graft was completely
occluded. Five patients underwent major amputation within 30 days and 3 further patientsnancial support have been used for this study. No conflict of interests for any author exists.
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332 E. Faglia et al.during the follow-up period. Patients were followed up until December 31 2007, with a mean
follow-up of 1.89 0.27 years. Restenosis occurred in 7 (28.0%) of the 25 patients in whom
a successful PTA was performed. In 5 of these 7 patients, PTA was repeated successfully. In
2 patients in whom a further PTA was not feasible a major amputation was performed. At
the end of the follow-up period the cumulative primary patency rate was 72%, the assisted
patency rate was 92%.
Conclusions: PTA is an effective method for revascularizing secondary obstructions in patients
with graft failure (and no possibility of a redo graft). PTA also is effective in at least one
subgenicular artery in patients with diabetes with inadequate run-off after femoropopliteal
bypass grafting.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Management of occluded bypass grafts (BPG) is complex.1
Despite all the efforts aiming at promptly locating stenoses
at the anastomotic sites, bypass obstructions rarely allow
recanalization by thrombectomy or thrombolysis.2,3 There-
fore, a new bypass may be the only alternative, or amputa-
tion. Failing bypass grafts in diabetic patients are more
difficult to identify than in nondiabetic patients, as early
signs of ischemia such as leg pain symptoms often may
be attenuated or absent.4,5 In such cases patients seek
medical attention because of deteriorating foot ulcers,
rather than because of pain. This is the same reason that
drives diabetic patients with inadequate run-off after
bypass grafting to seek medical advice.6e8
In January 2006 we started a prospective study for
diagnostic/therapeutic evaluation of diabetic patients
admitted to our footcare centre because of chronic limb
ischemia (CLI), according to 2000 TransAtlantic Inter-Society
Consensus (TASC).9 The aim of this study was to evaluate the
role of percutaneous peripheral angioplasty in the treat-
ment of patients consecutively admitted to our foot centre
because of failing bypass or residual CLI after BPG.
Methods
All diabetic patients referred to our foot centre because of
foot ulcer or rest pain were evaluated for the presence of
pedal pulses, and ankle-pressure and transcutaneous
oxygen tension (TcPO2) values were recorded. Posterior
tibial and dorsalis pedis pulses were evaluated by palpa-
tion, ankle-pressure was evaluated using a Doppler contin-
uous wave technique, and TcPO2 was evaluated at the
dorsum of the foot. Duplex scanning was performed in cases
with either reduced or absent foot pulses and TcPO2
<50 mmHg and/or ankle-pressure <70 mmHg. In patients
with BPG, duplex scanning was always performed. If
haemodynamically significant stenoses were documented
by duplex scanning, a digital subtraction arteriography
was carried out by means of a biplanar method and,
whenever possible, a PTA was performed concomitantly.
Interventional technique
PTA was indicated for angiographically documented obstruc-
tions narrowing>50% of the lumen vessel and was performedin the same time as angiography. The procedure was
performed under local anaesthesia through an antegrade
puncture of the ipsilateral common femoral artery. If
obstructions were documented by duplex scanning in the
iliac trunk or common femoral artery, the puncture was
performed by means of a contralateral approach. A 5- or
6-French vascular introducer was positioned to perform
a preliminary angiographic study using diluted (50%)
non-ionic contrast medium. An angiographic or PTCA
0.014e0.035-inch guidewire was inserted through any
arterial obstruction sites and a 3.0e5.0-French balloon
catheter was used for a 2e8 mm dilation of the arteries.
Vessel recanalization was considered successful if direct
flow was obtained in the treated vessel with no residual
stenosis>30% of the vessel diameter along the whole artery.
Stents were placed based on the interventional radiologist’s
opinion, mainly in the presence of a dissection or a parietal
thrombus or remaining stenosis >30% or recoil. During the
procedure a sodium heparin (5000e7000 IU) bolus was
infused into thearterial lumen. If vessel spasmoccurred, a ni-
troglycerine (0.1e0.2 mg) bolus was infused intra-arterially.
The occurrence of thrombi was managed by catheter aspira-
tion and/or urokinase and heparin infusion. All the
patients were prescribed either 30-day of ticlopidine
(500 mg/day) treatment followed by salicylic acid (100 mg/
day) indefinitely.
After hospital discharge, all patients with foot ulcers
were examined weekly until ulcer healing. In the absence
of symptoms, graft patency was assessed with Duplex at 30
days, 3, 6, 12 months and thereafter every 6 months,
according to the protocol of our Institute.
Statistical methods
We reported the descriptive statistics as average values and
standard deviation for the continuous variables and
percentages and contingency tables for the qualitative
and discrete variables. The difference between time to
admission after BPG failure and BPG patent with infrapo-
pliteal obstructed arteries was compared using Student’s
t test. The SPSS software package was used.
Results
During 2006, 531 diabetic patients were admitted to our
foot centre because of rest pain and/or foot ulcer. Of
these, 293 were affected by CLI according to the TASC 2000
Table 1 Demographic and clinical characteristics of study
population (NZ 32)
Age (years) 74.4 8.6
Females/males (n) 3 (9.4%)/29 (90.6%)
Insulin/oral therapy (n) 26 (81.3%)/6 (18.6)
Diabetes duration (years) 20.6 9.8
Coronary artery disease
(history) (n)
21 (65.6%)
Stroke (history) (n) 10 (31.3%)
Anti-hypertensive therapy (n) 16 (50.0%)
Lipid lowering therapy 31 (96.9%)
Creatinine> 133 mmol/l) (n) 22 (68.7%)
No/ex/current smokers (n) 14 (43.7%)/17
(53.1%)/1 (3.1%)
Data are % or mean 1 SD.
Table 2 Baseline anatomical situation of the seven
patients with patent graft
Patent BPG Infrapopliteal
patent arteries
before PTA
Infrapopliteal
patent arteries
after PTA
Ulcer
outcome
Femoropopliteal 0 Anterior tibial
þ peroneal
Dressing
Femoropopliteal 0 Peroneal 1st Ray
Femoropopliteal 0 Peroneal 1st Ray
Femoropopliteal 0 Peroneal Dressing
Femoropopliteal 0 Anterior tibial
þ peroneal
TM
Femoropopliteal 0 Peroneal TM
Femoropopliteal 0 Posterior tibial Dressing
TM: transmetatarsal amputation.
Angioplasty Advantage in Failing Bypass 333guidelines, and 32 of them had a previous history of
peripheral BPG, 26 femoropopliteal, 3 femoroposterior
tibial and 3 femoroperoneal. These 32 patients comprised
our study population with a mean follow up of 1.89 0.27
years, by December 31, 2007 (all patients remained alive
at this date).
Table 1 lists demographic and clinical characteristics of
this study population.Figure 1 Patent femoropopliteal bypass graft with all infrapopli
artery.Thirty-one grafts were performed with saphenous vein
and 1 femoro-posterior tibial vein graft had a polytetra-
fluoroethylene and venous cuff of the distal anastomosis.
All patients presented with foot ulcer: in 5 of them the
lesion was rather superficial, while in the remaining
patients the ulcer was deep and invading the bone
structures. Twenty-eight patients were suffering fromteal arteries occluded. Peripheral angiolasty of anterior tibial
Table 3 Baseline anatomical situation before and after PTA in the 25 patients with graft failure
Failing BPG Infrapopliteal patent
arteries before PTA
Infrapopliteal patent
arteries after PTA
Ulcer outcome
Femoropopliteal Anterior tibialþ peroneal Anterior tibialþ peroneal 1st Ray
Femoroposterior tibial 0 0 BK
Femoropopliteal 0 0 AKa
Femoropopliteal 0 Peroneal TM
Femoropopliteal 0 Peroneal 1st Toe
Femoropopliteal 0 Anterior tibial 5th Ray
Femoropopliteal Posterior tibialþ peroneal Posterior tibialþ peroneal 5th Ray
Femoropopliteal 0 0 Dressing
Femoropopliteal 0 Peroneal 4th Ray
Femoroposterior tibial 0 Posterior tibial BKb
Femoropopliteal 0 Anterior tibial Dressing
Femoropopliteal 0 Peroneal BKb
Femoropopliteal 0 0 AK
Femoroperoneal 0 Peroneal 5th Ray
Femoropopliteal 0 0 AK
Femoroperoneal 0 0 AK
Femoropopliteal 0 0 BK
Femoropopliteal 0 Peroneal 1st Ray
Femoropopliteal Peroneal Peroneal Dressing
Femoropopliteal Peroneal Peroneal Dressing
Femoroposterior tibial 0 Posterior tibial TM
Femoropopliteal Peroneal Peroneal TM
Femoroperoneal Peroneal Peroneal TM
Femoropopliteal 0 Peroneal 1st Ray
Femoropopliteal 0 Peroneal 5th Ray
BKZ below the knee amputation.
AKZ above the knee amputation.
TMZ transmetatarsal amputation.
a During follow-up after Chopart amputation.
b During follow-up because restenosis after PTA with no possibility of further revascularization procedure.
334 E. Faglia et al.intermittent pain; in the remaining 4 patients the pain was
continuous. The mean TcPO2 value was 14.4 14.1 mm
Hg. Ankle-pressure was not measurable in two patients
due to the presence of arterial calcification, and in 16
because of the absence of posterior tibial and pedal pulse:
in the remaining 14 patients with measurable ankle pres-
sure the mean value was 88.9 43.6 mmHg.
Thirteen patients had a failing graft. In 6 patients
a stenosis was identified in the distal anastomosis, and in
2 the stenosis was located at the proximal anastomosis; in 5
patients the stenosis was present at both the distal
and proximal anastomosis. Twelve patients had a totally
occluded graft. In 7 patients, all with femoropopliteal BPG,
the graft appeared patent; however, all the infrapopliteal
arteries were occluded. The mean time interval between
BPG surgery and subsequent hospital admission to our
footcare centre was 6.3 4.2 months for patients with
patent BPG and 20.5 12.0 months for those with failing/
failed BPG, pZ 0.004.
A technically successful PTAwas performed in 25 patients
(78.1%). This procedure was practicable in all the 7 patients
with patent BPG: Table 2 reports the baseline anatomical
situation, and patent arteries after PTA of these patients.
In all these 7 patients an antegrade puncture was used and
in any case a stent was placed (Fig. 1 shows an example).A technically successful PTA was performed in 18 out of
the 25 patients with failing or occluded BPG. Table 3
reports the baseline anatomical situation and patent
arteries after PTA of these patients. Recanalization of the
graft was obtained in all the 13 patients with a failing graft
without the use of stents (Fig. 2 shows an example. In 2
patients the puncture was contra-lateral and antegrade in
the remaining patients. Recanalization of native superficial
femoral artery occlusion by means of PTA was obtained in 5
out of the 12 patients in whom the graft was completely
occluded. In all these patients a stent Prote`ge`
150 6 mm (EV3 Corporate, Plymouth, USA) was placed in
the superficial femoral artery (Fig. 3 shows an example).
No complications were observed during or after the
procedure.
Eight (25%) patients underwent an above-the-ankle
amputation: none of these patients were suitable for
further PTA or bypass procedures: Six from the group of
non-revascularizable patients and 2 from the group of the
18 revascularized patients. The surgery was performed
within 30 days in 5 non-revascularizable patients and during
later follow up period in the remaining 3. Among these
latter 3 patients, one non revascularized patient with
a Chopart amputation required major amputation because
of a surgical site infection; the remaining 2 patients
Figure 2 Peripheral angioplasty performed on the distal occlusion of femoropopliteal bypass graft. PTA of the origin of anterior
tibial artery.
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nosis after PTA with no possibility of further revasculariza-
tion procedures. TcPO2 significantly (p< 0.001) improved
from 15.5 11.9 to 43.6 16.1 mmHg in the 25 patients
who underwent a successful PTA. In patients who suffered
major amputation, the TcPO2 measured at the time of
amputation, was 16.0 8.1 compared to 11.4 12.2 mmHg
before PTA, pZ 0.089. Ankle-pressure after PTA was not
measured.
Restenosis occurred in 7 (28.0%) of the 25 patients in
whom a successful PTA was performed. The cumulative
patency rate at end of follow-up was 72%. In 5 patients
a PTA procedure was repeated successfully. In 2 patients in
whom a further PTA was not feasible a major amputationwas performed. The cumulative assisted patency rate at
the end of follow-up was 92%.Discussion
Despite advances in surgical technique and effective
postoperative surveillance by clinical follow-up and serial
duplex examinations,10,11 infrainguinal vein graft closure
occurs in a rather consistent percentage of patients and
remains a major problem for revascularized patients with
BPG.12
Optimal treatment of graft stenosis or chronic occlusion
is subject of considerable debate on whether PTA or
Figure 3 Peripheral angioplasty and stent of the native superficial femoral artery in femoropopliteal occluded bypass graft.
Angioplasty of the anterior tibial and pedal arteries.
336 E. Faglia et al.surgical repair should be regarded as the preferred treat-
ment.13e15 Furthermore, replacement of a failed BPG with
a new BPG poses a variety of important problems, such as
vein availability for a new bypass grafting, and/or patient
comorbidities.16,17 This is particularly true for diabetic
patients with peripheral arteriopathy and foot ulcers, in
whom concomitant comorbidities such as ischemic heart
disease, hypertension, stroke and renal insufficiency may
be very frequent.18e20 Moreover, ischemic heart disease is
particularly common and may itself require bypass to limit
the availability of a second distal vein graft.21 All these
problems were evident in our series of 32 patients.
Although our follow up period was rather short; the
majority of BPG lesions develop within the first year of
surgery. Our data indicate that complete occlusion of BPGis a potentially catastrophic for limb salvage.22 Most of the
patients (6/7, 86%) in whom recanalization of totally
occluded grafts was not possible underwent amputation.
However we did achieve limb salvage in almost 50% of
patients with totally occluded BPG and no possibilities of
further bypass procedures. This is a positive outcome,
considering that in such conditions amputation is usually
inevitable.23 PTA was able to open the graft or maintain
patency in all grafts with stenosis or occlusion at the anas-
tomoses. Also, in many patients PTA was able to open at
least one infrapopliteal artery, to provide good run-off for
the existing BPG. Only 2 patients with failing grafts under-
went amputation due to graft occlusion after PTA.
Most of our patients were not eligible for a new BPG
because of absence of a graft recipient vessel. For this
Figure 3 (continued)
Angioplasty Advantage in Failing Bypass 337reason we cannot compare our series with others which
compared the feasibility and efficacy of surgical revisions
with PTA.24 It has been suggested that PTA often is followed
by further procedures to maintain viable blood supply to
the limb.25 However, we believe that a policy of aggressive
reinterventions is effective for optimizing the limb salvage
rate.
In our opinion the cases of the 7 patients, in whom the
BPG was patent but all 3 subgenicular arteries were
occluded, are of particular interest. It is well known that
a revascularization procedure that does not improve foot
circulation is useless when attempting to salvage limbs.26
Femoropopliteal bypass grafts with poor distal run-off
are doomed to premature occlusion and are pointless. Such
grafts do not eliminate chronic limb ischemia and leave the
patient at high risk of amputation soon after attempted
revascularisation.27e30 Perhaps in such cases infrapopliteal
PTA should be performed at the time of bypass surgery.
Our data indicate that PTA is a feasible and an effective
procedure for many diabetic patients with failing BPG and
with no further surgical options for revascularization. PTA
appears to be even more practicable and effective inpatients in whom the BPG is patent but the infrapopliteal
arteries are occluded.
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